Total Payments
$1.2M
2024 Payments
$114,638
Companies
32
Transactions
1,038
Medicare Patients
2,646
Medicare Billing
$206,487
Payment Breakdown by Category
Other$882,531 (75.8%)
Consulting$172,902 (14.8%)
Travel$76,038 (6.5%)
Food & Beverage$26,002 (2.2%)
Research$6,993 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $873,531 | 332 | 75.0% |
| Consulting Fee | $172,902 | 76 | 14.8% |
| Travel and Lodging | $76,038 | 303 | 6.5% |
| Food and Beverage | $26,002 | 315 | 2.2% |
| Honoraria | $9,000 | 3 | 0.8% |
| Unspecified | $6,993 | 9 | 0.6% |
Payments by Type
General
$1.2M
1,029 transactions
Research
$6,993
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $409,987 | 457 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $202,489 | 154 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $194,316 | 130 | $0 (2019) |
| Esperion Therapeutics, Inc. | $106,668 | 76 | $0 (2024) |
| Amarin Pharma Inc. | $85,973 | 64 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $40,687 | 24 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $31,521 | 16 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $28,790 | 26 | $0 (2024) |
| Merck Sharp & Dohme LLC | $13,572 | 19 | $0 (2023) |
| PFIZER INC. | $11,599 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114,638 | 136 | Amgen Inc. ($42,529) |
| 2023 | $72,316 | 65 | Amgen Inc. ($26,108) |
| 2022 | $84,493 | 76 | Esperion Therapeutics, Inc. ($26,527) |
| 2021 | $92,730 | 72 | Amgen Inc. ($36,464) |
| 2020 | $129,217 | 102 | Amgen Inc. ($70,681) |
| 2019 | $248,516 | 214 | Amgen Inc. ($106,436) |
| 2018 | $246,513 | 201 | SANOFI-AVENTIS U.S. LLC ($95,237) |
| 2017 | $176,043 | 172 | Amgen Inc. ($58,392) |
All Payment Transactions
1,038 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $3,770.00 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $515.39 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $114.48 | General |
| 11/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,508.00 | General |
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $462.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/25/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,908.00 | General |
| 10/25/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,954.00 | General |
| 10/25/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $977.00 | General |
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,538.00 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 10/21/2024 | Medicure Pharma Inc. | Zypitamag (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $119.59 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 09/26/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $83.54 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $42.00 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $34.78 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $934.00 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $121.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $206.40 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $254.24 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $120.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/17/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Travel and Lodging | Cash or cash equivalent | $77.72 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $100.45 | General |
| Category: Cardiology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Research Publication/ Writing Support | Novartis Pharmaceuticals Corporation | $3,552 | 2 |
| Alirocumab expanded access program for the treatment of patients with severe hypercholesterolemia not controlled with maximal tolerated dose of lipid-lowering therapy administered according to standar | SANOFI-AVENTIS U.S. LLC | $1,690 | 2 |
| Alirocumab Expanded Access Program for the Treatment of Patients with Severe Hypercholesterolemia Not Controlled with Maximal Tolerated Doses of Lipid-Lowering Therapy Administered According to Stand | SANOFI-AVENTIS U.S. LLC | $1,002 | 2 |
| Alirocumab Expanded Access Program | SANOFI-AVENTIS U.S. LLC | $748.86 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 543 | 677 | $150,635 | $47,685 |
| 2022 | 4 | 453 | 573 | $118,986 | $41,339 |
| 2021 | 7 | 477 | 540 | $163,727 | $43,373 |
| 2020 | 14 | 1,173 | 1,277 | $458,495 | $74,090 |
Total Patients
2,646
Total Services
3,067
Medicare Billing
$206,487
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 201 | 279 | $72,261 | $24,979 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 148 | 184 | $47,656 | $13,354 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $16,544 | $5,685 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $9,856 | $2,447 | 24.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 99 | 118 | $2,596 | $991.20 | 38.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $1,722 | $229.71 | 13.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 265 | $62,275 | $24,139 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 113 | 135 | $31,725 | $10,035 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $13,024 | $4,077 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 25 | 25 | $8,800 | $2,676 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 79 | 99 | $2,178 | $292.92 | 13.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 12 | $984.00 | $119.74 | 12.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 158 | $35,392 | $15,348 | 43.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 122 | 143 | $32,032 | $10,764 | 33.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 53 | 54 | $45,018 | $6,887 | 15.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $13,640 | $5,656 | 41.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 37 | 37 | $23,791 | $2,002 | 8.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 15 | 15 | $5,115 | $1,634 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 14 | $2,135 | $579.40 | 27.1% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 43 | 48 | $2,688 | $321.08 | 11.9% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 11 | 11 | $3,476 | $121.00 | 3.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 20 | 20 | $440.00 | $60.00 | 13.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 228 | 232 | $191,461 | $35,097 | 18.3% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 170 | 177 | $112,579 | $10,579 | 9.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 118 | 127 | $27,051 | $7,589 | 28.1% |
About Dr. Alan Brown, MD
Dr. Alan Brown, MD is a Cardiovascular Disease healthcare provider based in Naperville, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386698694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Brown, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $114,638 received in 2024. These payments were reported across 1,038 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($873,531).
As a Medicare-enrolled provider, Brown has provided services to 2,646 Medicare beneficiaries, totaling 3,067 services with total Medicare billing of $206,487. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Naperville, IL
- Active Since 05/20/2006
- Last Updated 09/05/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1386698694
Products in Payments
- Repatha (Biological) $406,470
- PRALUENT (Drug) $194,101
- PRALUENT ALIROCUMAB INJECTION (Biological) $106,999
- NEXLIZET (Drug) $103,565
- Vascepa (Drug) $85,973
- EVKEEZA (Biological) $68,200
- Livalo (Drug) $35,343
- EPANOVA (Drug) $31,528
- PRALUENT (Biological) $27,529
- LEQVIO (Drug) $23,527
- ELIQUIS (Drug) $11,526
- JUXTAPID (Drug) $7,664
- WatchPATONE (Device) $6,061
- NEXLETOL (Drug) $3,104
- Zypitamag (Drug) $2,721
- ZYPITAMAG (Drug) $1,653
- HMG-CoA reductase inhibitor (Drug) $1,500
- Liposober (Device) $1,500
- ZYPITAMAG (pitavastatin) (Drug) $1,000
- WatchPAT (Device) $833.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Naperville
Moeen Saleem, Md, MD
Cardiovascular Disease — Payments: $415,209
Cardiovascular Disease $415,209
Mark Goodwin, Md, MD
Cardiovascular Disease — Payments: $212,105
Cardiovascular Disease $212,105
Dr. Sujith Kalathiveetil, M.d, M.D
Cardiovascular Disease — Payments: $134,907
Cardiovascular Disease $134,907
Dr. Krishna Nagendran, Md, MD
Cardiovascular Disease — Payments: $96,761
Cardiovascular Disease $96,761
Ron Oren, Md, MD
Cardiovascular Disease — Payments: $65,024
Cardiovascular Disease $65,024
Dr. Aman Ali, M.d, M.D
Cardiovascular Disease — Payments: $50,248
Cardiovascular Disease $50,248